← Back to all trials
Not Yet Recruiting
NCT07650799
AI-assisted Rare Disease Diagnosis
Conditions: Rare Disorders, Rare Diseases
Sex: All
Ages: 0 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 1056
Sponsor: Peking Union Medical College Hospital
Location: Peking Union Medical College Hospital Beijing
Summary
A multicentre randomised controlled trial evaluating whether a rare-disease diagnostic large language model can improve diagnostic quality, efficiency, and health-economic outcomes for physicians managing patients with suspected rare or diagnostically unresolved disease.
Eligibility Criteria
Patient Inclusion Criteria:
* Any age. Legal guardian co-signs consent for minors or individuals lacking legal capacity.
* Diagnostically unresolved or suspected rare disease, with at least one prior complete clinical evaluation at a secondary-level or higher institution yielding no confirmed explanatory diagnosis.
* First presentation to the enrolling institution for the current condition, with no prior records in the institutional HIS or outpatient system.
* No prior genetic testing related to the current condition; no results or reports available.
* Written informed consent provided voluntarily by patient or legal guardian, with commitment and ability to complete structured follow-up.
Patient Exclusion Criteria:
* Confirmed diagnosis (clinical, pathological, or molecular) explaining the primary symptoms.
* Emergency presentation, critical illness, or any condition incompatible with trial participation.
* Neither patient nor legally authorised proxy able to complete follow-up.
* Concurrent enrollment in another interventional study with diagnostic accuracy or genetic testing yield as a primary endpoint.
* Prior use of another AI system has already yielded a confirmed diagnosis for the current condition.
Physician Inclusion Criteria
* Licensed physician in internal medicine, neurology, pediatrics, general medicine, rare disease, or a related specialty.
* ≥2 years of clinical practice; competent to manage rare disease patients; stratified into junior or senior tier.
* Voluntary participation with written informed consent.
Physician Exclusion Criteria
* No longer in clinical practice, or unable to fulfill required outpatient duties during the study period.
* Unwilling to provide informed consent or to permit protocol-required collection of consultation and questionnaire data.
* Currently enrolled in another AI-assisted clinical workflow, or expected to be unable to comply with the procedures.
Source: ClinicalTrials.gov (NCT07650799). StuddyBuddy aggregates publicly available trial information.